Criteria for permanent exemption from donating blood and its components
(absolute contraindications for blood donation)
| Medical state or disease, as well as diagnostic and treatment procedures | Criteria |
| Infectious diseases | HIV infection, viral hepatitis B, viral hepatitis C, syphilis, tuberculosis, brucellosis, typhoid, tularemia, leprosy. |
| Parasitic diseases | Echinococcosis, alveococcosis, toxoplasmosis, trypanosomiasis, filariasis, Guinea disease, leishmaniasis, malaria. |
| Somatic diseases | Malignant neoplasms, blood diseases, organic diseases of the central nervous system, complete lack of hearing and speech, complete lack of vision, mental illnesses, drug addiction, alcoholism, epilepsy. |
| Cardiovascular diseases | High blood pressure stage II-III, coronary heart disease, atherosclerosis, atherosclerotic cardio sclerosis, endocarditis, myocarditis, heart defects, obliterating endarteritis. Persons with a history of heart disease, especially coronary artery disease, angina pectoris, severe cardiac arrhythmias, cerebrovascular disorders, arterial thromboembolism or recurrent venous thrombosis (see also Hypertension). |
| Respiratory system diseases | Bronchial asthma, lung emphysema, obstructive bronchitis, diffuse pneumosclerosis in the stage of decompensation. |
| Digestive system diseases | Peptic ulcer of the stomach and duodenum, anacid gastritis, chronic liver diseases, calculous cholecystitis, cholangitis, cirrhosis of the liver. |
| Kidney and urinary tract diseases | Diffuse and focal kidney damage, urolithiasis disease. |
| Radiation sickness | Persons who received and suffered from radiation. |
| Endocrine system diseases | In case of significant malfunction and metabolism. Diabetes – if a donor receives insulin. |
| Diseases of ENT organs | Empyema of the paranasal sinuses, sinusitis, ozena. |
| Eye diseases | Parenchymal keratitis, trachoma, high myopia (6 diopters or more), residual effects of uveitis (iritis, iridocyclitis, chorioretinitis). |
| Skin diseases | Common skin diseases of an inflammatory and infectious nature. Generalized psoriasis, erythroderma, eczema. Sycosis, systemic lupus erythematosus, blistering dermatoses, vitiligo, fungal skin lesions (trichophytosis, epidermophytosis, favus, microsporia), pustular skin diseases (pyoderma, furunculosis). |
| Osteomyelitis | Acute, chronic. |
| Surgical interventions | Resection and removal of organs (stomach, kidney, gall bladder, ovary, uterus, eyes, body parts). Transplantation of organs and tissues. |
| Oncological diseases/malignant neoplasms | Persons who have a malignant neoplasm or who have had cancer in the past. In certain instances, a doctor responsible for allowing donors to give blood may make an exception to this rule. |
| Creutzfeldt-Jakob disease | All persons who have ever been treated with extracts or extracts of the human pituitary gland. Persons who have received a pachymeninx or corneal transplant, and persons with a family history indicating an increased risk of Creutzfeldt-Jakob disease or other transmissible spongiform encephalopathy. Note: A family history of CJD indicates an increased risk of CJD in a potential donor, unless: (a) the affected family member has a variant form of CJD (in CJD) rather than CJD; (b) the affected family member is not genetically related to the potential donor; (c) the patient family member was infected with CJD iatrogenically; (d) the potential donor was examined for polymorphisms in the gene encoding the PrPc protein, and the analysis did not reveal any abnormalities. |
| Medications | Any use of drugs through injections. |
| Persons at risk | Drug addicts, prostitutes, homosexuals, people released from prison. |
| Healthcare professionals | Persons who have contact with blood due to their professional activities. |
| Xenotransplantation | All recipients. |
Criteria for temporary exemption from donation of blood and its components
(relative contraindications)
| № | Name | Medical exemption term |
| 1. | Factors of infection with blood-borne diseases: | |
| 1.1. | Transfusion of blood and its components | 6 months |
| 1.2. | Operations (including abortion) | 6 months |
| 1.3. | Tattooing, piercing, acupuncture | 6 months |
| 1.4. | Staying on a business trip abroad for more than 2 months | 6 months |
| 1.5. | Staying in malaria-endemic countries with tropical and subtropical climates (Africa, Asia, South and Central America) for more than 3 months | 3 years |
| 1.6. | Contact with patients with hepatitis A, E | 35 days |
| 1.7. | Contact with patients with hepatitis B, C | 6 months |
| 2. | Previous diseases: | |
| 2.1. | Typhoid fever after recovery and full clinical examination in the absence of apparent functional disorders | 1 year |
| 2.2. | Sore throat, flu, ARVI | 1 month after recovery |
| 2.3. | Other infectious diseases | 6 months after recovery |
| 2.4. | Dental extraction | 10 days |
| 2.5. | Acute and chronic inflammatory states in the acute stage, irrespective of their location | 1 month after relief of the acute period |
| 2.6. | Allergic diseases in the acute stage | 1 month after the aggravation is relieved |
| 3. | Pregnancy period | 1 year after birth |
| 4. | Lactation period | 3 months after the end of lactation, but not earlier than 1 year after birth |
| 5. | Menstruation period | 5 days after completion |
| 6. | Vaccinations: | |
| 6.1. | Vaccination with inactivated vaccines (hepatitis B, tetanus, diphtheria, whooping cough, typhoid, paratyphoid, cholera, flu) and toxoids | 10 days |
| 6.2. | Vaccination with live vaccines (brucellosis, plague, smallpox, rubella, tularemia, polio, BCG vaccine), administration of anti-tetanus serum (in the absence of apparent inflammatory processes at the injection site) | 1 month |
| 6.4. | Vaccination against rabies | 1 year |
| 7. | Taking medications: | |
| 7.1. | Antibiotics | 2 weeks after the end of treatment |
| 7.2. | Analgesics, salicylates | 3 days after the end of treatment |
| 8. | Use of alcohol | 48 hours |
Note: In case a donor has diseases which are not included in this list, the question of blood donation is decided by a transfusiologist, and if needed, after consulting a specialist in the appropriate field.